What is the treatment for essential tremor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Essential Tremor

Propranolol (80-240 mg/day) or primidone are the first-line treatments for essential tremor, effective in up to 70% of patients, with propranolol being the most established medication having demonstrated efficacy for over 40 years. 1

When to Initiate Treatment

  • Treatment should only be started when tremor symptoms interfere with function or quality of life, not simply because tremor is present. 1
  • For tremor that is disabling only during periods of stress or anxiety, propranolol or benzodiazepines can be used intermittently during those specific periods. 2

First-Line Pharmacological Options

Propranolol:

  • Dosage range: 80-240 mg/day 1, 3
  • Most established medication with over 40 years of demonstrated efficacy 4, 1
  • Can provide dual benefits in patients with both essential tremor and hypertension 1, 5

Primidone:

  • Equally effective first-line option recommended by the American Academy of Neurology 1
  • Therapeutic benefit can occur even when derived phenobarbital levels remain subtherapeutic, confirming primidone itself has anti-tremor properties 1
  • Clinical benefits may not become apparent for 2-3 months, so an adequate trial period is essential 1
  • Women of childbearing age must be counseled about teratogenic risks (neural tube defects) 1
  • Behavioral disturbances, irritability, and sleep disturbances can occur, particularly at higher doses 1

Alternative Beta-Blockers

If propranolol causes adverse effects, other beta-blockers may be tried:

  • Nadolol: 40-320 mg daily 1
  • Metoprolol: 25-100 mg extended release daily or twice daily 4, 1
  • Timolol: 20-30 mg/day 1
  • Atenolol: Limited evidence for moderate effect 1, 2

Second-Line Medications

If first-line agents fail or are not tolerated:

  • Topiramate: Established efficacy as second-line option 6, 7
  • Gabapentin: Limited evidence for moderate efficacy 1, 7
  • Benzodiazepines (e.g., clonazepam): Can provide benefit, particularly in patients with associated anxiety 2, 7

Combination Therapy

  • If either primidone or propranolol alone do not provide adequate tremor control, they can be used in combination. 2

Critical Contraindications and Precautions

Beta-blockers should be avoided in:

  • Chronic obstructive pulmonary disease 1, 5
  • Bradycardia 1, 5
  • Congestive heart failure 1, 5

Common adverse effects of beta-blockers include:

  • Fatigue and depression 1
  • Dizziness and hypotension 1
  • Exercise intolerance and sleep disorders 1
  • Cold extremities and bronchospasm 1
  • In elderly patients, excessive heart rate reduction may lead to serious adverse events 1

Botulinum Toxin for Selected Cases

  • For disabling head or voice tremor, botulinum toxin injections into the muscles may provide relief 2
  • Botulinum toxin in hand muscles can result in bothersome hand weakness and is not widely used 2

Surgical Options for Medication-Refractory Tremor

Surgical therapies should be considered when medications fail due to lack of efficacy at maximum doses, dose-limiting side effects, or medical contraindications. 1

Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy:

  • Shows sustained tremor improvement of 56% at 4 years 1, 3
  • Lower complication rate (4.4%) compared to radiofrequency thalamotomy (11.8%) and deep brain stimulation (21.1%) 1, 5
  • Early adverse effects include gait disturbance (36%) and paresthesias (38%), which decrease to 9% and 14% respectively by 1 year 1
  • Serious adverse events are rare (1.6%) 1
  • Contraindications: Cannot undergo MRI, skull density ratio <0.40, bilateral treatment needed, or previous contralateral thalamotomy 1, 5

Deep Brain Stimulation (DBS):

  • Provides adjustable, reversible tremor control that can be optimized over time 1
  • Preferred for bilateral tremor involvement 1
  • Preferred for relatively young patients as it offers an adjustable treatment option 1
  • Ventral intermediate nucleus (VIM) of the thalamus is the established target 1
  • Provides adequate tremor control in approximately 90% of patients 2

Radiofrequency Thalamotomy:

  • Available but carries higher complication risks (11.8%) than MRgFUS 1
  • Only rarely done if DBS or focused ultrasound is not possible 6

Treatment Algorithm

  1. Initiate treatment only when tremor interferes with function or quality of life 1
  2. Start with propranolol (80-240 mg/day) OR primidone 1
  3. If inadequate response, try the alternative first-line agent or combine both 2
  4. If first-line agents fail, consider topiramate or gabapentin 1, 6
  5. For medication-refractory tremor causing significant disability:
    • Unilateral tremor or patients with medical comorbidities: MRgFUS thalamotomy preferred 1
    • Bilateral tremor or contraindications to MRgFUS: DBS 1

References

Guideline

Medications for Tremor Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Postural Tremor Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differentiating Essential Tremor from Intentional Tremor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Managing Essential Tremor.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.